- Home
- VTVT vs RAND Comparison
VTVT vs RAND Comparison
Compare VTVT & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTVT
- RAND
- Stock Information
- Founded
- VTVT 2015
- RAND 1969
- Country
- VTVT United States
- RAND United States
- Employees
- VTVT N/A
- RAND N/A
- Industry
- VTVT Biotechnology: Pharmaceutical Preparations
- RAND Finance: Consumer Services
- Sector
- VTVT Health Care
- RAND Finance
- Exchange
- VTVT Nasdaq
- RAND Nasdaq
- Market Cap
- VTVT 47.9M
- RAND 54.4M
- IPO Year
- VTVT 2015
- RAND N/A
- Fundamental
- Price
- VTVT $21.03
- RAND $15.21
- Analyst Decision
- VTVT Strong Buy
- RAND
- Analyst Count
- VTVT 2
- RAND 0
- Target Price
- VTVT $35.50
- RAND N/A
- AVG Volume (30 Days)
- VTVT 3.4K
- RAND 5.0K
- Earning Date
- VTVT 11-11-2025
- RAND 11-05-2025
- Dividend Yield
- VTVT N/A
- RAND 11.03%
- EPS Growth
- VTVT N/A
- RAND N/A
- EPS
- VTVT N/A
- RAND N/A
- Revenue
- VTVT $17,000.00
- RAND $7,966,118.00
- Revenue This Year
- VTVT N/A
- RAND N/A
- Revenue Next Year
- VTVT N/A
- RAND N/A
- P/E Ratio
- VTVT N/A
- RAND N/A
- Revenue Growth
- VTVT N/A
- RAND 1.16
- 52 Week Low
- VTVT $12.62
- RAND $13.82
- 52 Week High
- VTVT $26.99
- RAND $31.89
- Technical
- Relative Strength Index (RSI)
- VTVT 75.87
- RAND 46.04
- Support Level
- VTVT $19.15
- RAND $14.50
- Resistance Level
- VTVT $21.40
- RAND $15.25
- Average True Range (ATR)
- VTVT 1.20
- RAND 0.66
- MACD
- VTVT 0.32
- RAND 0.03
- Stochastic Oscillator
- VTVT 92.81
- RAND 31.70
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.